| Authors: |
Sirkisson S; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Zikhali N; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Chang C; Department of Infectious Diseases, Alfred Hospital, Melbourne, Australia.; Department of Infectious Diseases, School of Translational Medicine, Monash University, Melbourne, Australia., Ndung'u T; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Africa Health Research Institute, Durban, South Africa.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of TechnologyandHarvard University, Cambridge, MA, USA.; Division of Infection and Immunity, University College London, London, UK., Sojane K; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Ndlovu B; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa. ndlovub3@ukzn.ac.za. |
